Grow your business safely with OHRE PHARMA

All the information you need about OHRE PHARMA to develop and secure your business in France

O HOME > CORPORATES > OHRE PHARMA > BALANCE SHEET ( 2020-05-15)

THE LIST OF BALANCE SHEET : OHRE PHARMA

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-07-25 Public 2021-12-31 Complete
2020-05-15 Partially confidential 2019-12-31 Complete
2018-06-12 Partially confidential 2017-12-31 Complete
NameOHRE PHARMA
Siren799926266
Closing2019-12-31
Registry code 3701
Registration number 2331
Management number2014B00095
Activity code 4646Z
Closing date n-12018-12-31
Duration Fiscal year 12
Duration Fiscal year n-100
Filing date2020-05-15
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPartially confidential
Address37000 TOURS
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AF Concessions, Patents and Similar Rights 818 870.00 254 662.00 564 207.00 818 870.00
AL Advances and down payments on intangible assets. 212 548.00 212 548.00 212 548.00
AT Other tangible assets 76 261.00 18 679.00 57 581.00 76 261.00
BH Other financial assets 69 602.00 69 602.00 69 602.00
BJ TOTAL (I) 1 395 267.00 273 342.00 1 121 924.00 1 395 267.00
BT Goods 993 642.00 993 642.00 993 642.00
BV Advances and down payments on orders 2 026.00 2 026.00 2 026.00
BX Customers and related accounts 1 475 878.00 1 475 878.00 1 475 878.00
BZ Other receivables 62 592.00 62 592.00 62 592.00
CD Marketable securities 515 861.00 515 861.00 515 861.00
CF Cash and cash equivalents 1 377 285.00 1 377 285.00 1 377 285.00
CH Prepaid expenses 26 696.00 26 696.00 26 696.00
CJ TOTAL (II) 4 453 981.00 4 453 981.00 4 453 981.00
CO Grand total (0 to V) 5 924 815.00 273 342.00 5 651 472.00 5 924 815.00
CU Other investments 1 766.00 1 766.00 1 766.00
CW Deferred expenses or loan issuance costs 75 565.00 75 565.00 75 565.00
CX Development or Research and Development Expenses 216 217.00 216 217.00 216 217.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 26 765.00 26 765.00 26 765.00
DB Share, merger, contribution premiums, etc. 1 319 608.00 1 319 608.00 1 319 608.00
DD Legal reserve (1) 2 676.00 2 676.00
DG Other reserves 65 342.00 65 342.00
DH Retained earnings -104 259.00
DI RESULTS FOR THE YEAR (Profit or Loss) 518 857.00 272 278.00 518 857.00
DJ Investment subsidies 185 000.00 185 000.00
DL TOTAL (I) 2 118 249.00 1 514 392.00 2 118 249.00
DN Conditional advances 11 183.00 11 183.00 11 183.00
DO TOTAL (II) 11 183.00 11 183.00 11 183.00
DQ Provisions for Expenses 40 862.00 40 862.00 40 862.00
DR TOTAL (IV) 40 862.00 40 862.00 40 862.00
DS Convertible Bond Issues 804 550.00 1 000 000.00 804 550.00
DU Loans and Debts from Credit Institutions (3) 1 348 567.00 940 559.00 1 348 567.00
DV Miscellaneous Loans and Financial Debts (4) 18 457.00 4 658.00 18 457.00
DX Trade payables and related accounts 955 888.00 754 461.00 955 888.00
DY Tax and social security liabilities 244 370.00 179 726.00 244 370.00
EA Other liabilities 109 343.00 1 972.00 109 343.00
EC TOTAL (IV) 3 481 177.00 2 881 378.00 3 481 177.00
EE Grand total (I to V) 5 651 472.00 4 447 815.00 5 651 472.00
EG Accrued income and payables due within one year 1 640 498.00 1 426 828.00 1 640 498.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 685 903.00 709 363.00 685 903.00
CZ ACQUISITIONS: Establishment, Development, or Research Expenses 63 715.00 152 501.00 63 715.00
I3 DECREASES Total Financial Fixed Assets 71 369.00
I4 DECREASES Grand Total 1 395 267.00
IN DECREASES Start-up, development, or research expenses 216 217.00
IO DECREASES Total including other intangible assets 1 031 418.00
IY DECREASES Total Tangible Fixed Assets 76 261.00
KD ACQUISITIONS Total including other intangible assets 551 624.00 479 793.00 551 624.00
LN ACQUISITIONS Total Tangible Fixed Assets 26 035.00 50 226.00 26 035.00
LQ ACQUISITIONS Total Financial Fixed Assets 44 527.00 26 841.00 44 527.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 147 465.00 125 876.00 147 465.00
PE DEPRECIATION Total including other intangible assets 134 215.00 120 447.00 134 215.00
QU DEPRECIATION Total Tangible Fixed Assets 13 250.00 5 429.00 13 250.00
7 - Provisions Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
5B Provisions for taxes
5Z Total provisions for risks and expenses 40 862.00 40 862.00
7C Grand total 40 862.00 40 862.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
7Y Gross convertible bonds with a maturity of up to one year 804 550.00 206 850.00 597 700.00 804 550.00
8A Miscellaneous Loans and Financial Debts 10 285.00 10 285.00 10 285.00
8B Suppliers and Related Accounts 955 888.00 955 888.00 955 888.00
8D Social Security and Other Social Organizations 244 082.00 244 082.00 244 082.00
8K Other liabilities (including liabilities related to repo transactions) 109 343.00 109 343.00 109 343.00
UT Other financial assets 69 602.00 69 602.00 69 602.00
UX Other trade receivables 1 475 878.00 1 475 878.00 1 475 878.00
VH Loans with a maturity of more than one year at origin 1 348 567.00 105 588.00 967 979.00 1 348 567.00
VI Group and Associates 8 460.00 8 460.00 8 460.00
VJ Loans taken out during the year 500 000.00 500 000.00
VK Loans repaid during the year 287 442.00 287 442.00
VR Miscellaneous debtors (including receivables related to repo transactions) 62 592.00 62 592.00 62 592.00
VS Prepaid expenses 26 696.00 26 696.00 26 696.00
VT TOTAL – STATEMENT OF RECEIVABLES 1 634 768.00 1 565 166.00 69 602.00 1 634 768.00
VY TOTAL – STATEMENT OF LIABILITIES 3 481 177.00 1 640 498.00 1 565 679.00 3 481 177.00

all companies in France

Complete and comprehensive database.